Click on a filter below to refine your search. Remove a filter to broaden your search.
The victims include people of all ages and occupations and from all 50 states.
For every starting age between 50 and 80 years, the projected mean event-free survival was numerically greater with finerenone versus placebo.
Older adults with long-term benzodiazepine receptor agonist use and an insomnia diagnosis had significant improvements in sleep outcomes.
The findings were seen among adult psychiatric inpatients taking an antipsychotic.
A reduced risk for Alzheimer’s disease, vascular dementia and Parkinson’s disease was seen with SGLT2i use in type 2 diabetes.
The medication already was approved for advanced disease.
Once-weekly efsitora was noninferior to once-daily degludec for a decrease in the mean glycated hemoglobin level.
Black beneficiaries have lower average doses in the first 90 days.
The mean home systolic blood pressure was lower with the triple-pill protocol versus the standard-care protocol at month 6.
The findings were seen for both primary care patients with hypertension and nursing home residents.